Gyre Therapeutics Inc (GYRE)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -31.493 | -65.75 | -36.556 | -49.382 | -58.16 | -116.848 | -19.599 | -128.198 |
Return on Equity (%) | -71.353 | -108.921 | -39.882 | -58.612 | -77.893 | -150.11 | -84.969 | 2401.37 |
Return on Invested Capital (%) | -86.433 | -93.673 | -45.082 | -61.102 | -81.331 | -154.723 | -254.067 | -254.2 |
Operating Margin (%) | -4246.867 | -2117.976 | -500916.667 | N/A | -268.479 | -1198.324 | -994.207 | -67.84 |
Net Profit Margin (%) | -4246.867 | -2506.09 | -500916.667 | N/A | -268.479 | -1198.324 | -1038.035 | -81.915 |
Book Value Per Share | 20.039 | 5.061 | 10.033 | 5.675 | 3.442 | 1.308 | 0.308 | 2.061 |
Earnings Per Share | -21.128 | -4.195 | -2.514 | -4.583 | -2.545 | -2.8 | -0.218 | -2.447 |
Cash Per Share | 12.798 | 2.38 | 2.611 | 1.276 | 1.374 | 1.412 | 0.574 | 0.882 |
Working Capital Per Share | 19.397 | 4.994 | 9.97 | 5.578 | 3.245 | 1.188 | 0.301 | 0.979 |
Operating Profit Per Share | 0.498 | 0.167 | 0.001 | N/A | 0.533 | -0.001 | N/A | 2.893 |
EBIT Per Share | -21.128 | -3.546 | -2.514 | -4.583 | -2.545 | -2.8 | -0.209 | -2.027 |
EBITDA Per Share | -21.128 | -3.546 | -2.514 | -4.583 | -2.545 | -2.8 | -0.209 | -2.027 |
Free Cash Flow Per Share | -21.03 | -4.22 | -2.495 | -4.589 | -2.539 | -2.809 | 1.168 | -2.249 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 802k | 6,08M | 11,96M | 12,04M | 22,1M | 31,41M | 37,76M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 37,76M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | 45.933 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | 27.72 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,03B |
Ratio cours/bénéfice | -10,09 |
Ratio prix/ventes | 8,27 |
Ratio prix/liquidités | 27,99 |
Ratio prix/valeur comptable | 11,95 |
Rendement de dividende | - |
Actions en circulation | 93,52M |
Volume moyen (1 semaine) | 194,99k |
Volume moyen (1 mois) | 119,34k |
Variation sur 52 semaines | -52,29% |
Plus haut sur 52 semaines | 30,40 |
Plus bas sur 52 semaines | 8,26 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales